Omeros | OMER - Market Capitalization


Omeros reported $702.8M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 3.49B 853M Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Cytokinetics USD 6.58B 2.63B Sep/2025
Dynavax Technologies USD 1.16B 26M Sep/2025
Gilead Sciences USD 183.59B 31.31B Feb/2026
Heron Therapeutics USD 145M 6M Sep/2023
Immunic USD 68M 2M Dec/2023
Insmed USD 30.44B 11.35B Sep/2025
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
MacroGenics USD 114M 8M Feb/2026
Omeros USD 184M 158M Sep/2023
Pacira USD 1.16B 51M Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
Rockwell Medical USD 59M 33M Sep/2023
Sarepta Therapeutics USD 2.02B 336M Sep/2025
United Therapeutics USD 18.96B 6B Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025
Xoma USD 162M 55M Sep/2023